Dr. Shikha Jain of Northwestern Medicine in Chicago told Reuters Health, “A ctDNA analysis may be a way to detect minimal residual disease with the possibility of uncovering treatment failure earlier than was possible previously.”
Source: Liquid Biopsy Promising for Monitoring Post-cystectomy Bladder Cancer
